Crinetics Pharmaceuticals Inc (CRNX)
56.76
+0.07
(+0.12%)
USD |
NASDAQ |
Nov 04, 13:06
Crinetics Pharmaceuticals 1 Year Total Returns (Daily): 91.84% for Nov. 1, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
November 01, 2024 | 91.84% |
October 31, 2024 | 91.06% |
October 30, 2024 | 92.28% |
October 29, 2024 | 98.66% |
October 28, 2024 | 101.8% |
October 25, 2024 | 103.7% |
October 24, 2024 | 97.64% |
October 23, 2024 | 106.7% |
October 22, 2024 | 102.1% |
October 21, 2024 | 98.98% |
October 18, 2024 | 107.2% |
October 17, 2024 | 105.4% |
October 16, 2024 | 100.8% |
October 15, 2024 | 97.87% |
October 14, 2024 | 82.41% |
October 11, 2024 | 95.73% |
October 10, 2024 | 91.99% |
October 09, 2024 | 89.18% |
October 08, 2024 | 92.48% |
October 07, 2024 | 92.70% |
October 04, 2024 | 107.4% |
October 03, 2024 | 93.08% |
October 02, 2024 | 99.04% |
October 01, 2024 | 74.58% |
September 30, 2024 | 71.82% |
Date | Value |
---|---|
September 27, 2024 | 81.06% |
September 26, 2024 | 76.30% |
September 25, 2024 | 70.38% |
September 24, 2024 | 72.87% |
September 23, 2024 | 74.95% |
September 20, 2024 | 85.71% |
September 19, 2024 | 83.33% |
September 18, 2024 | 84.32% |
September 17, 2024 | 79.69% |
September 16, 2024 | 82.91% |
September 13, 2024 | 88.51% |
September 12, 2024 | 67.47% |
September 11, 2024 | 94.56% |
September 10, 2024 | 215.6% |
September 09, 2024 | 227.1% |
September 06, 2024 | 203.9% |
September 05, 2024 | 203.8% |
September 04, 2024 | 202.8% |
September 03, 2024 | 198.3% |
August 30, 2024 | 221.2% |
August 29, 2024 | 219.0% |
August 28, 2024 | 219.4% |
August 27, 2024 | 218.9% |
August 26, 2024 | 211.0% |
August 23, 2024 | 195.3% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-54.47%
Minimum
Mar 18 2020
236.2%
Maximum
Aug 21 2024
26.45%
Average
5.43%
Median
1 Year Total Returns (Daily) Benchmarks
PTC Therapeutics Inc | 119.3% |
Zevra Therapeutics Inc | 88.76% |
Clearside Biomedical Inc | 32.37% |
Biomea Fusion Inc | -13.49% |
NovaBay Pharmaceuticals Inc | -93.74% |